Holders over time
- DGX
- ELV
| Quarter | DGX | ELV |
|---|---|---|
| Q3 2020 | 18 holders, $1.0bn | 30 holders, $15.0bn |
| Q4 2020 | 21 holders, $1.1bn | 29 holders, $16.7bn |
| Q1 2021 | 19 holders, $1.2bn | 25 holders, $18.6bn |
| Q2 2021 | 14 holders, $975m | 30 holders, $19.4bn |
| Q3 2021 | 17 holders, $1.1bn | 26 holders, $18.5bn |
| Q4 2021 | 17 holders, $1.5bn | 29 holders, $23.3bn |
| Q1 2022 | 16 holders, $812m | 31 holders, $23.9bn |
| Q2 2022 | 16 holders, $813m | 32 holders, $23.3bn |
| Q3 2022 | 16 holders, $910m | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $1.1bn | 34 holders, $25.5bn |
| Q1 2023 | 17 holders, $989m | 39 holders, $22.5bn |
| Q2 2023 | 16 holders, $1.3bn | 38 holders, $20.6bn |
| Q3 2023 | 15 holders, $1.1bn | 34 holders, $19.8bn |
| Q4 2023 | 11 holders, $1.2bn | 36 holders, $20.3bn |
| Q1 2024 | 10 holders, $777m | 35 holders, $21.3bn |
| Q2 2024 | 13 holders, $1.2bn | 33 holders, $22.1bn |
| Q3 2024 | 11 holders, $1.7bn | 30 holders, $20.2bn |
| Q4 2024 | 9 holders, $1.6bn | 32 holders, $15.9bn |
| Q1 2025 | 10 holders, $1.8bn | 28 holders, $17.1bn |
| Q2 2025 | 10 holders, $2.4bn | 27 holders, $14.8bn |
| Q3 2025 | 13 holders, $2.5bn | 27 holders, $12.7bn |
| Q4 2025 | 10 holders, $1.5bn | 25 holders, $17.0bn |
| Q1 2026 | 9 holders, $1.6bn | 26 holders, $13.6bn |
| Q2 2026 | 7 holders, $1.6bn | 28 holders, $17.7bn |
Quest Diagnostics Inc
- Holders
- 11
- Reported value
- $1.7bn
- Buyers
- 6
- Sellers
- 5
Breadth +1 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 30
- Reported value
- $20.2bn
- Buyers
- 16
- Sellers
- 16
Breadth 0 among 94 comparable managers.
Who holds both, Q3 2024
Both (9)
AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Invesco Ltd, Man Group PLC, T. Rowe Price Associates Inc, Wellington Management Group LLP
Only DGX (2)
Only ELV (21)
Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Holocene Advisors LP, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Tudor Investment Corp, Two Sigma Investments LP, Verition Fund Management LLC, Voloridge Investment Management LLC
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.